Sharemaestro Newsreel

Align Technology Prevails in China Patent Infringement Action

Align Technology (ALGN) disclosed late Tuesday that the Jinan Intermediate People's Court in China issued a judgment in its favor, in a patent infringement action against Angelalign Technology's operating subsidiaries in China.The company provides an orthodontic treatment system Silver Upgrade to read this MT …

Ascletis Pharma (SEHK:1672) At 5x P B On Obesity Trial Momentum Looks About Right

Align Technology Prevails in China Patent Infringement Action Against Angelalign

SAN JOSE, Calif. & TEMPE, Ariz., August 12, 2026--(BUSINESS WIRE)--Align Technology, Inc. ("Align") (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, today announced that the Jinan Intermediate People's Court in China issued a …

Belenos Biosciences Announces Positive Topline Results from a Phase 2 Clinical Trial of BEL512 in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)

The study met its primary and all secondary endpoints at Week 24 Rapid onset of clinical activity was observed with significant improvements as early as Week 4 Durable clinical activity demonstrated following single-dose administration, supporting 6- month dosing for the treatment of CRSwNP '512 …

MicroPort CardioFlow Signals Revenue Surge as CRM Acquisition Fuels Global Growth

Asian Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading

Asian equities traded in the US as American depositary receipts were edging slightly lower Tuesday morning, declining 0.14% to 3,020.40 on the S&P Asia 50 ADR Index.From North Asia, the gainers were led by diagnostic imaging centers company Concord Medical Services (CCM) and Silver …

Concord Healthcare Schedules Board Meeting to Review Interim Results and Dividend

Vincent Medical Sets August Board Meeting to Approve Interim Results and Dividend

Cutia Therapeutics (HKG:2487): Are Analysts Optimistic?

Yidu Tech Unit Wins RMB8.6 Million Hospital IT Infrastructure Contract

Hony Media Group Sets August Board Meeting to Approve Interim Results and Dividend

Antengene Sets Board Meeting to Approve 2026 Interim Results

Broncus Holding Corporation (2216.HK) stock price, news, quote and history

Wenzhou Kangning Hospital Posts Higher Revenue but Lower Profit in First Half of 2026

Wenzhou Kangning Hospital Declares Interim Dividend and Sets Withholding Tax Rules

Wenzhou Kangning Hospital Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026

Junshi Biosciences Discloses Reduction in Major Shareholder’s Equity Stake

Shanghai Junshi Biosciences Reports Completion of Shareholder’s Stake Reduction

Shanghai Conant Optical Seeks Shareholder Approval for RMB500 Million Bond Issuance

Town Health shifts Bermuda registered office while maintaining Hong Kong share registrar

Shanghai INT Medical Sets Extraordinary General Meeting and Closes Register of Members

Peijia Medical Sets Board Meeting to Approve Interim Results and Consider Dividend

Akeso Advances IO2.0 + ADC2.0 Strategy: First Patient Dosed in Phase II Study of TROP2/Nectin-4 Bispecific ADC (AK146D1) Combined with Ivonescimab in Breast Cancer

HONG KONG, Aug. 10, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the first patient has been dosed in a Phase II clinical study (AK146D1-202) evaluating AK146D1, the Company's internally developed TROP2/Nectin-4 bispecific antibody-drug conjugate (bsADC), in combination with ivonescimab …

Is Zai Lab’s (ZLAB) Rising Loss on Softer Revenue Reframing Its Investment-Led Growth Story?

Zai Lab Limited reported second-quarter 2026 results showing revenue of US$106.31 million versus US$109.98 million a year earlier, with net loss widening to US$50.83 million from US$40.73 million and basic loss per share increasing to US$0.50 from US$0.40. Over the first half of 2026, …

Innovent Biologics and Daiichi Sankyo Enter Exclusive Agreement for VANFLYTA® Commercialization in China

Collaboration to accelerate access to Vanflyta® for patients with newly diagnosed FLT3-ITD positive AML SAN FRANCISCO and SUZHOU, China, Aug. 9, 2026 /PRNewswire/ -- Innovent Biologics, Inc. (01801.HK) and Daiichi Sankyo (TSE: 4568), have entered into an exclusive agreement for the commercialization of Vanflyta® …

Shanghai Henlius Biotech (SEHK:2696) Advances Oncology Pipeline, Is It Still 64% Below Fair Value?

Zai Lab (ZLAB) Rebounds Following Earnings While Its Undervalued Narrative Faces A Fresh Test

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Zai Lab (ZLAB) stock is in focus after the company reported second quarter 2026 …

Enterprise value to revenue forward of MicroTech Medical (Hangzhou) Co., Ltd. Class H – HKEX:2235

ETFs Investing in Guangzhou Innogen Pharmaceutical Group Co Ltd Class H Stocks

Price to earnings forward of Shanghai Conant Optical Co. Ltd. Class H – HKEX:2276

Raily Aesthetic Medicine Issues Positive Profit Alert with Revenue and Profit Turnaround for H1 202612

Hony Media Flags Large Stake Sale After Unusual Trading Activity

Raily Aesthetic Medicine Shifts Hong Kong Principal Office to Tsim Sha Tsui

Raily Aesthetic Medicine Signals Interim Profit on Strong Aesthetic Services and Equipment Sales

Qyuns Therapeutics Sets Board Meeting to Approve 2026 Interim Results

Laekna Schedules Board Meeting to Approve 2026 Interim Results